📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. (2022)

First Author: Oza B

Attributed to: Cambridge Mathematics of Information in Healthcare (CMIH) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.01090

PubMed Identifier: 35213214

Publication URI: http://europepmc.org/abstract/MED/35213214

Type: Journal Article/Review

Volume: 40

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 16

ISSN: 0732-183X